New Medications Are Needed for Children With Juvenile Idiopathic Arthritis is a research paper published in Arthritis & Rheumatology (2020). On theSindex it has a DataRank of 0. It has been cited 61 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: P30‐AR‐076316
Intramural NIH HHS
Grant: Z01 ES101081
NIAMS NIH HHS
Grant: P30 AR076316
National Institute of Environmental Health Sciences
FWCI
3.32
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study
Additional file 1 of Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study
Additional file 1 of S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis
Additional file 1 of S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis
Additional file 2 of S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis
Additional file 2 of S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis